UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000027442 |
|---|---|
| Receipt number | R000031442 |
| Scientific Title | Phase I/II clinical trial for therapeutic HB vaccine containing HBsAg and HBcAg |
| Date of disclosure of the study information | 2017/05/22 |
| Last modified on | 2022/11/24 10:03:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/05/22 16:58:33 | ||
| 2 | Update | 2018/11/26 17:01:52 | Target sample size |
|
| 3 | Update | 2020/12/01 10:31:38 | Date of IRB Last follow-up date |
|
| 4 | Update | 2020/12/01 10:36:46 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Tel1 Email1 Organization Organization Address Address Tel |
|
| 5 | Update | 2022/11/24 10:03:18 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 6 | Update | 2022/11/24 10:03:54 | Recruitment status |
